About MAXWELL BIOSCIENCES, INC.
Maxwell Biosciences is a biotechnology company focused on developing a Biomimetic Immune System™ technology to reverse aspects of immunosenescence and combat infectious diseases. The company's drug development platform was incubated by DARPA, DOE, and NIH, and its lead candidate, MXB-22,510, shows broad-spectrum antiviral and antibacterial activity.
Is this your company?
Claim MAXWELL BIOSCIENCES, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim MAXWELL BIOSCIENCES, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.